The Robot-Assisted Endoscopes Market Size, Share & Global Insights (2021–2031)
The robot-assisted endoscopes market is projected to grow from US$ 292.94 million in 2024 to US$ 515.53 million by 2031, at a CAGR of 8.4% from 2025 to 2031.
🌐 Executive Summary & Market Insights
As hospitals increasingly adopt advanced, p... moreRobot-Assisted Endoscopes Market Size, Share & Global Insights 2021–2031
The Robot-Assisted Endoscopes Market Size, Share & Global Insights (2021–2031)
The robot-assisted endoscopes market is projected to grow from US$ 292.94 million in 2024 to US$ 515.53 million by 2031, at a CAGR of 8.4% from 2025 to 2031.
🌐 Executive Summary & Market Insights
As hospitals increasingly adopt advanced, precise, and minimally invasive technologies, robot-assisted endoscopes are seeing rapid uptake—particularly in gastroenterology, urology, gynecology, and thoracic surgery. These systems enable complex procedures with enhanced precision, faster recovery times, and reduced healthcare costs.
The rising burden of chronic diseases like cancer, coupled with a growing preference for less invasive procedures, is driving market expansion.
________________________________________
🔎 Market Segmentation Highlights:
• By Product Type:
▪️ Diagnostic
▪️ Therapeutic (Dominated in 2024)
• By Application:
▪️ Laparoscopy
▪️ Colonoscopy
▪️ Gastrointestinal Endoscopy (Dominated in 2024)
▪️ Others
• By End User:
▪️ Hospitals (Largest share in 2024)
▪️ Specialty Clinics
▪️ Ambulatory Surgical Centers
▪️ Others
________________________________________
🚀 Market Drivers & Opportunities
✔️ Growing demand for minimally invasive surgeries
✔️ Enhanced surgical precision & visualization
✔️ Surge in chronic conditions (e.g., GI diseases, urological disorders)
✔️ Reduced hospital stays & overall treatment costs
________________________________________
🏥 Key Market Players
• Medtronic
• Intuitive Surgical
• Stryker Corporation
• Moon Surgical
• Asensus Surgical
• Meril
• Novus
• MicroPort Scientific Corp
________________________________________
📊 Report Coverage Includes:
• Global, regional, and country-level forecasts
• Market trends, SWOT & Porter’s Five Forces analysis
• Competitive landscape and key developments
• Detailed company profiles
________________________________________
Stay ahead in healthcare innovation.
📊 Powered by: Business Market Insights
________________________________________
About Us
Business Market Insights delivers in-depth, data-rich market intelligence across verticals such as healthcare, electronics, automotive, aerospace, and chemicals. Our expert research and actionable insights support strategic decisions globally.
The global neodymium iron boron (NdFeB) permanent magnet market is projected to grow significantly, reaching US$ 29,129.11 million by 2031, up from US$ 15,204.23 million in 2024. This growth reflects a robust CAGR of 10.3% during the forecast period from 2025 to 2031.
___________________________... moreNeodymium-Iron-Boron Permanent Magnet Market Size, Share & Global Insights 2021–2031
The global neodymium iron boron (NdFeB) permanent magnet market is projected to grow significantly, reaching US$ 29,129.11 million by 2031, up from US$ 15,204.23 million in 2024. This growth reflects a robust CAGR of 10.3% during the forecast period from 2025 to 2031.
________________________________________
Executive Summary & Global Market Analysis
The NdFeB magnet market is witnessing strong momentum, fueled by increasing adoption of high-performance, energy-efficient technologies across diverse industries. These magnets are known for their exceptional magnetic strength, compact size, and versatility—attributes that make them indispensable in electric vehicles (EVs), wind turbines, consumer electronics, and medical devices.
Key growth drivers include:
• The global transition to renewable energy sources
• Rapid electrification in automotive and industrial sectors
• Miniaturization and automation of electronic devices
Emerging trends such as recycling of rare earth elements, supply chain resilience, and environmental sustainability are reshaping the competitive landscape. Market players are also heavily investing in advanced manufacturing technologies and collaborative R&D to enhance performance and sustainability.
Despite the market’s dominance by established Asian manufacturers, new opportunities are opening for companies that can deliver differentiated value such as higher magnet quality, local supply chains, and lower carbon footprints.
📥 Click Here to Download Sample Report
________________________________________
Market Segmentation Analysis
By Type:
• Sintered NdFeB Magnets (Dominant in 2024)
• Bonded NdFeB Magnets
By End-User:
• Automotive (Leading segment)
• Consumer Electronics
• Power Generators (Wind Turbines)
• Industrial Automation & Robotics
• Medical Devices
• Others
By Geography:
• North America
• Europe
• Asia-Pacific (Leading region)
• Middle East & Africa
• South & Central America
________________________________________
Key Market Drivers and Opportunities
Electrification of Transportation
The increasing adoption of electric vehicles globally is one of the strongest drivers of NdFeB magnet demand. These magnets are critical components in EV motors, offering unmatched energy efficiency and magnetic strength. Regulatory mandates, consumer preferences for cleaner mobility, and infrastructure investments are further fueling this trend.
Industrial Automation and Energy Sector Growth
The global shift toward automation, smart manufacturing, and wind energy generation also significantly contributes to the demand for high-performance NdFeB magnets.
________________________________________
Type-Based Market Insights
Sintered NdFeB magnets held the largest market share in 2024. These magnets are produced using powder metallurgy, providing superior temperature stability, demagnetization resistance, and magnetic performance—ideal for demanding applications in EVs, renewable energy, and robotics.
________________________________________
Key Players in the NdFeB Magnet Market
• Hitachi Metals, Ltd.
• Shin-Etsu Chemical Co., Ltd.
• TDK Corporation
• Ningbo Yunsheng Co., Ltd.
• Beijing Zhong Ke San Huan High-Tech Co., Ltd.
• Vacuumschmelze GmbH & Co. KG
• Neo Performance Materials Inc.
________________________________________
About Us
Business Market Insights provides data-rich intelligence across industries like healthcare, electronics, automotive, aerospace, and chemicals. Our actionable insights help global stakeholders make informed strategic decisions.
The global laparoscopes market is poised for significant growth, projected to reach US$ 6,746.51 million by 2031, up from US$ 3,535.70 million in 2024, growing at a robust CAGR of 9.7% between 2025 and 2031.
________________________________________
Executive Summary & Market Overview
The market is witnessing strong momentum due to:
• The wid... moreLaparoscopes Market Size, Share & Global Insights 2021–2031
The global laparoscopes market is poised for significant growth, projected to reach US$ 6,746.51 million by 2031, up from US$ 3,535.70 million in 2024, growing at a robust CAGR of 9.7% between 2025 and 2031.
________________________________________
Executive Summary & Market Overview
The market is witnessing strong momentum due to:
• The widespread adoption of high-definition (HD), 3D, and 4K laparoscopes
• Increasing volume of minimally invasive procedures
• Rise in same-day surgeries and outpatient care demand
Technological advancements, such as 4K and 3D imaging systems, are reshaping the surgical landscape. 4K systems offer four times the resolution of HD, enhancing precision and image clarity, despite higher costs. A 2024 systematic review of 23 randomized trials found 3D laparoscopes reduced operative time and potential blood loss. However, recent NCBI studies (2025) suggest some clinicians may favor 4K systems for visual clarity, despite mild side effects.
📥 Download Free Sample PDF: Click Here
________________________________________
Executive Summary and Global Market Analysis:
The global laparoscopes market is experiencing significant growth driven by shift toward high-definition visualization, growing laparoscopic procedure volume, and surge in same-day surgeries. Laparoscopic devices encompass rigid laparoscopes, flexible laparoscopes, and robot-assisted laparoscopes. This segment's leading position is bolstered by the advancement of High-Definition (HD), 3D, and 4K laparoscopes, rapidly becoming the standard of care.
Market Segmentation Overview
By Product:
• Rigid Laparoscopes (largest market share in 2024)
• Flexible Laparoscopes
• Robot-Assisted Laparoscopes
By Application:
• General Surgery (leading segment)
• Bariatric Surgery
• Gynecological Surgery
• Colorectal Surgery
• Others
By End User:
• Hospitals & Clinics (dominant in 2024)
• Ambulatory Surgical Centers
________________________________________
Growth Drivers and Opportunities
🔍 High-Definition Imaging as a Game Changer
The shift to HD and 4K systems has improved laparoscopic surgery precision. Earlier systems often lacked resolution, creating difficulties in complex dissections. Today, enhanced visualization minimizes surgical errors and improves outcomes.
________________________________________
Key Market Players
• Medtronic Plc
• Johnson & Johnson
• Olympus Corp
• Stryker Corp
• Karl Storz SE & Co KG
• Boston Scientific Corp
• B Braun SE
• Smith & Nephew Plc
• Conmed Corp
• Intuitive Surgical Inc
________________________________________
Report Coverage
This report provides in-depth analysis, including:
• Global, regional, and country-level forecasts
• Key market trends and dynamics
• SWOT analysis
• Competitive landscape with heatmap analysis
• Detailed company profiles
• Regulatory and reimbursement frameworks
________________________________________
About Us
Business Market Insights delivers in-depth, data-rich market intelligence across verticals such as healthcare, electronics, automotive, aerospace, and chemicals. Our expert research and actionable insights support strategic decisions globally.
The global cancer chemotherapy market is poised for substantial growth — projected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024, registering an impressive CAGR of 11.5% from 2025 to 2031.
🔍 Executive Summary & Market Dynamics:
The global cancer chemotherapy market is experiencing significant growth ... moreCancer Chemotherapy Market Size, Share & Global Insights (2022–2031)
The global cancer chemotherapy market is poised for substantial growth — projected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024, registering an impressive CAGR of 11.5% from 2025 to 2031.
🔍 Executive Summary & Market Dynamics:
The global cancer chemotherapy market is experiencing significant growth driven by rising global incidence of cancer coupled with an aging population, increasing access to oncology care in emerging markets, and combination with surgery, radiation, and targeted therapies. Cancer therapeutics encompasses alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and others. Chemotherapy can stop or slow down the growth of cells through the cytotoxic ability of drugs
Growth is fueled by the rising global incidence of cancer, an aging population, and expanding access to oncology care, particularly in emerging markets. Chemotherapy — encompassing alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, and mitotic inhibitors — remains a cornerstone of cancer treatment.
According to NIH estimates, around 650,000 cancer patients in the US receive chemotherapy each year. The therapeutic goal: shrink tumors to facilitate surgical removal and improve patient outcomes.
📥 Grab Sample PDF to Learn More:
👉 Download PDF Sample
________________________________________
🔬 Market Segmentation:
• By Therapy Type: Alkylating agents dominate, driven by their broad applicability and affordability.
• By Indication: Lung cancer led market share in 2024.
• By Distribution Channel: Hospital pharmacies held the largest share.
________________________________________
🌍 Key Growth Driver:
Increased access to oncology care in emerging markets such as Asia-Pacific, Latin America, and parts of Africa is a major driver. Investments in healthcare infrastructure, universal health coverage, and inclusion of chemotherapy drugs in essential medicine lists are improving treatment access significantly.
________________________________________
🧪 Leading Companies:
• Astellas Pharma Inc
• Eli Lilly and Co
• Novartis AG
• Merck KGaA
• Johnson & Johnson
• AstraZeneca
• Pfizer Inc
• Bristol Myers Squibb
• F. Hoffmann-La Roche Ltd
• AbbVie
________________________________________
📊 About Us:
Business Market Insights delivers intelligent, data-driven insights across healthcare, automotive, electronics, aerospace, and more—empowering stakeholders to make informed strategic decisions.
The Robot-Assisted Endoscopes Market Size, Share & Global Insights (2021–2031)
The robot-assisted endoscopes market is projected to grow from US$ 292.94 million in 2024 to US$ 515.53 million by 2031, at a CAGR of 8.4% from 2025 to 2031.
The Robot-Assisted Endoscopes Market Size, Share & Global Insights (2021–2031)
The robot-assisted endoscopes market is projected to grow from US$ 292.94 million in 2024 to US$ 515.53 million by 2031, at a CAGR of 8.4% from 2025 to 2031.
🌐 Executive Summary & Market Insights
As hospitals increasingly adopt advanced, precise, and minimally invasive technologies, robot-assisted endoscopes are seeing rapid uptake—particularly in gastroenterology, urology, gynecology, and thoracic surgery. These systems enable complex procedures with enhanced precision, faster recovery times, and reduced healthcare costs.
The rising burden of chronic diseases like cancer, coupled with a growing preference for less invasive procedures, is driving market expansion.
The global Magnetic Resonance Imaging (MRI) Systems Market is projected to grow from USD 14,168.84 million in 2024 to USD 20,333.64 million by 2031, expanding at a CAGR of 5.3% from 2025 to 2031.
🌍 Global Market Overview:
The demand for MRI systems continues to rise due to increasing inci... moreMagnetic Resonance Imaging (MRI) Systems Market Size, Share & Global Insights (2022–2031)
The global Magnetic Resonance Imaging (MRI) Systems Market is projected to grow from USD 14,168.84 million in 2024 to USD 20,333.64 million by 2031, expanding at a CAGR of 5.3% from 2025 to 2031.
🌍 Global Market Overview:
The demand for MRI systems continues to rise due to increasing incidences of neurological disorders, cancer, and cardiovascular diseases that require advanced imaging technologies. Innovations such as high-field MRI scanners and AI-powered imaging software are significantly improving diagnostic speed and accuracy. Furthermore, growing healthcare infrastructure in emerging markets is enhancing accessibility and adoption of MRI systems.
AI integration is emerging as a key driver, streamlining image interpretation, boosting diagnostic confidence, and improving overall clinical workflows.
However, high equipment and maintenance costs remain a barrier in resource-limited settings, especially among smaller clinics and diagnostic centers. Despite this, ongoing innovation and healthcare modernization are expected to sustain market growth globally.
The global laparoscopes market is poised for significant growth, projected to reach US$ 6,746.51 million by 2031, up from US$ 3,535.70 million in 2024, growing at a robust CAGR of 9.7% between 2025 and 2031.
________________________________________
Executive Summary & Market Overview
The market is witnessing strong momentum due to:
• The wid... moreLaparoscopes Market Size, Share & Global Insights 2021–2031
The global laparoscopes market is poised for significant growth, projected to reach US$ 6,746.51 million by 2031, up from US$ 3,535.70 million in 2024, growing at a robust CAGR of 9.7% between 2025 and 2031.
________________________________________
Executive Summary & Market Overview
The market is witnessing strong momentum due to:
• The widespread adoption of high-definition (HD), 3D, and 4K laparoscopes
• Increasing volume of minimally invasive procedures
• Rise in same-day surgeries and outpatient care demand
Technological advancements, such as 4K and 3D imaging systems, are reshaping the surgical landscape. 4K systems offer four times the resolution of HD, enhancing precision and image clarity, despite higher costs. A 2024 systematic review of 23 randomized trials found 3D laparoscopes reduced operative time and potential blood loss. However, recent NCBI studies (2025) suggest some clinicians may favor 4K systems for visual clarity, despite mild side effects.
The global cancer chemotherapy market is poised for substantial growth — projected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024, registering an impressive CAGR of 11.5% from 2025 to 2031.
🔍 Executive Summary & Market Dynamics:
The global cancer chemotherapy market is experiencing significant growth ... moreCancer Chemotherapy Market Size, Share & Global Insights (2022–2031)
The global cancer chemotherapy market is poised for substantial growth — projected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024, registering an impressive CAGR of 11.5% from 2025 to 2031.
🔍 Executive Summary & Market Dynamics:
The global cancer chemotherapy market is experiencing significant growth driven by rising global incidence of cancer coupled with an aging population, increasing access to oncology care in emerging markets, and combination with surgery, radiation, and targeted therapies. Cancer therapeutics encompasses alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and others. Chemotherapy can stop or slow down the growth of cells through the cytotoxic
ability of drugs
Growth is fueled by the rising global incidence of cancer, an aging population, and expanding access to oncology care, particularly in emerging markets. Chemotherapy — encompassing alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, and mitotic inhibitors — remains a
cornerstone of cancer treatment.
According to NIH estimates, around 650,000 cancer patients in the US receive chemotherapy each year. The therapeutic goal: shrink tumors to facilitate surgical removal and improve patient outcomes.
Cancer Chemotherapy Market Size, Share & Global Insights (2022–2031)
The global cancer chemotherapy market is poised for substantial growth — projected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024, registering an impressive CAGR of 11.5% from 2025 to 2031.
🔍 Executive Summary & Market Dynamics:
Growth is fueled by the rising global incidence of cancer, an aging population, and expanding access to oncology care, particularly in emerging markets. Chemotherapy — enco... moreCancer Chemotherapy Market Size, Share & Global Insights (2022–2031)
The global cancer chemotherapy market is poised for substantial growth — projected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024, registering an impressive CAGR of 11.5% from 2025 to 2031.
🔍 Executive Summary & Market Dynamics:
Growth is fueled by the rising global incidence of cancer, an aging population, and expanding access to oncology care, particularly in emerging markets. Chemotherapy — encompassing alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, and mitotic inhibitors — remains a cornerstone of cancer treatment.
According to NIH estimates, around 650,000 cancer patients in the US receive chemotherapy each year. The therapeutic goal: shrink tumors to facilitate surgical removal and improve patient outcomes.
📥 Grab Sample PDF to Learn More:
👉 https://www.businessmarketinsights.com/reports/cancer-chemotherapy-market
________________________________________
🔬 Market Segmentation:
• By Therapy Type: Alkylating agents dominate, driven by their broad applicability and affordability.
• By Indication: Lung cancer led market share in 2024.
• By Distribution Channel: Hospital pharmacies held the largest share.
________________________________________
🌍 Key Growth Driver:
Increased access to oncology care in emerging markets such as Asia-Pacific, Latin America, and parts of Africa is a major driver. Investments in healthcare infrastructure, universal health coverage, and inclusion of chemotherapy drugs in essential medicine lists are improving treatment access significantly.
________________________________________
🧪 Leading Companies:
• Astellas Pharma Inc
• Eli Lilly and Co
• Novartis AG
• Merck KGaA
• Johnson & Johnson
• AstraZeneca
• Pfizer Inc
• Bristol Myers Squibb
• F. Hoffmann-La Roche Ltd
• AbbVie
________________________________________
📊 About Us:
Business Market Insights delivers intelligent, data-driven insights across healthcare, automotive, electronics, aerospace, and more—empowering stakeholders to make informed strategic decisions.
Laparoscopes Market Size, Share & Global Insights 2021–2031
The global laparoscopes market is poised for significant growth, projected to reach US$ 6,746.51 million by 2031, up from US$ 3,535.70 million in 2024, growing at a robust CAGR of 9.7% between 2025 and 2031.
________________________________________
Executive Summary & Market Overview
The market is witnessing strong momentum due to:
• The widespread adoption of high-definition (HD), 3D, and 4K laparoscopes
• Increasing volume of mi... moreLaparoscopes Market Size, Share & Global Insights 2021–2031
The global laparoscopes market is poised for significant growth, projected to reach US$ 6,746.51 million by 2031, up from US$ 3,535.70 million in 2024, growing at a robust CAGR of 9.7% between 2025 and 2031.
________________________________________
Executive Summary & Market Overview
The market is witnessing strong momentum due to:
• The widespread adoption of high-definition (HD), 3D, and 4K laparoscopes
• Increasing volume of minimally invasive procedures
• Rise in same-day surgeries and outpatient care demand
Technological advancements, such as 4K and 3D imaging systems, are reshaping the surgical landscape. 4K systems offer four times the resolution of HD, enhancing precision and image clarity, despite higher costs. A 2024 systematic review of 23 randomized trials found 3D laparoscopes reduced operative time and potential blood loss. However, recent NCBI studies (2025) suggest some clinicians may favor 4K systems for visual clarity, despite mild side effects.
📥 Download Free Sample PDF: Click Here- https://www.businessmarketinsights.com/reports/laparoscopes-market
________________________________________
Market Segmentation Overview
By Product:
• Rigid Laparoscopes (largest market share in 2024)
• Flexible Laparoscopes
• Robot-Assisted Laparoscopes
By Application:
• General Surgery (leading segment)
• Bariatric Surgery
• Gynecological Surgery
• Colorectal Surgery
• Others
By End User:
• Hospitals & Clinics (dominant in 2024)
• Ambulatory Surgical Centers
________________________________________
Growth Drivers and Opportunities
🔍 High-Definition Imaging as a Game Changer
The shift to HD and 4K systems has improved laparoscopic surgery precision. Earlier systems often lacked resolution, creating difficulties in complex dissections. Today, enhanced visualization minimizes surgical errors and improves outcomes.
________________________________________
Key Market Players
• Medtronic Plc
• Johnson & Johnson
• Olympus Corp
• Stryker Corp
• Karl Storz SE & Co KG
• Boston Scientific Corp
• B Braun SE
• Smith & Nephew Plc
• Conmed Corp
• Intuitive Surgical Inc
________________________________________
Report Coverage
This report provides in-depth analysis, including:
• Global, regional, and country-level forecasts
• Key market trends and dynamics
• SWOT analysis
• Competitive landscape with heatmap analysis
• Detailed company profiles
• Regulatory and reimbursement frameworks
________________________________________
About Us
Business Market Insights delivers in-depth, data-rich market intelligence across verticals such as healthcare, electronics, automotive, aerospace, and chemicals. Our expert research and actionable insights support strategic decisions globally.
Magnetic Resonance Imaging (MRI) Systems Market Size, Share & Global Insights (2022–2031)
The global Magnetic Resonance Imaging (MRI) Systems Market is expected to expand from USD 14,168.84 million in 2024 to USD 20,333.64 million by 2031, growing at a CAGR of 5.3% between 2025 and 2031.
________________________________________
🌍 Global Market Overview
The rising incidence of neurological disorders, cancer, and cardiovascular diseases is driving strong demand for MRI systems as these conditi... moreMagnetic Resonance Imaging (MRI) Systems Market Size, Share & Global Insights (2022–2031)
The global Magnetic Resonance Imaging (MRI) Systems Market is expected to expand from USD 14,168.84 million in 2024 to USD 20,333.64 million by 2031, growing at a CAGR of 5.3% between 2025 and 2031.
________________________________________
🌍 Global Market Overview
The rising incidence of neurological disorders, cancer, and cardiovascular diseases is driving strong demand for MRI systems as these conditions increasingly rely on advanced imaging for diagnosis and treatment planning. The adoption of high-field MRI systems and AI-powered imaging platforms is revolutionizing diagnostic capabilities by enhancing speed, precision, and workflow efficiency.
Emerging economies are seeing rapid healthcare infrastructure expansion, further accelerating market penetration. While high costs of MRI equipment and maintenance present challenges—especially for smaller facilities—continuous innovation and increasing healthcare investments are expected to offset these barriers, supporting sustainable market growth.
________________________________________
📩 Grab Your PDF Sample To Know More -https://www.businessmarketinsights.com/reports/magnetic-resonance-imaging-mri-systems-market
________________________________________
🔍 Market Segmentation Overview
By Type:
• Closed MRI Systems (dominant)
• Open MRI Systems
By Field Strength:
• Low-Field
• Mid-Field (leading segment)
• High & Ultra-High Field
By Mobility:
• Fixed MRI Systems (dominant)
• Portable MRI Systems
By Application:
• Neurology (largest share)
• Oncology
• Cardiology
• Orthopedics
• Gastroenterology
• Gynecology
• Others
By End User:
• Hospitals (primary segment)
• Diagnostic Imaging Centers
• Specialty Clinics
• Research Institutes
• Others
________________________________________
🚀 Key Market Drivers
Rising Chronic & Neurological Diseases:
Conditions such as Alzheimer’s, epilepsy, and multiple sclerosis are increasing globally. According to the WHO, over 1.8 million people live with multiple sclerosis worldwide, highlighting the demand for accurate, early diagnostics.
Technological Advancements:
Continual improvements in image resolution, gradient technology, and AI-enabled image analysis are enhancing the speed, safety, and accuracy of MRI diagnostics.
________________________________________
🏥 Leading Market Players
• GE HealthCare
• Siemens Healthineers AG
• FUJIFILM Holdings Corporation
• Canon Inc.
• Koninklijke Philips N.V.
• Hyperfine, Inc.
• Esaote SpA
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
________________________________________
📰 Recent Developments
📅 May 12, 2025 – GE HealthCare unveiled its SIGNA Sprint, a next-generation 1.5T wide-bore MRI system, at ISMRM 2025. This system offers advanced performance, streamlined workflows, and enhanced imaging versatility.
________________________________________
📊 About Us
Business Market Insights delivers accurate, industry-focused market research across sectors including Healthcare, Aerospace, Electronics, Automotive, Chemicals, and more. Our experienced analysts ensure that clients gain meaningful, actionable insights to drive strategic decisions.
Neodymium-Iron-Boron Permanent Magnet Market Size, Share & Global Insights (2021–2031)
The global Neodymium-Iron-Boron (NdFeB) permanent magnet market is poised for substantial expansion, projected to grow from US$ 15,204.23 million in 2024 to US$ 29,129.11 million by 2031, registering a CAGR of 10.3% during the forecast period (2025–2031).
________________________________________
🌐 Executive Summary & Global Market Outlook
The NdFeB magnet market is experiencing accelerated growth driven by... moreNeodymium-Iron-Boron Permanent Magnet Market Size, Share & Global Insights (2021–2031)
The global Neodymium-Iron-Boron (NdFeB) permanent magnet market is poised for substantial expansion, projected to grow from US$ 15,204.23 million in 2024 to US$ 29,129.11 million by 2031, registering a CAGR of 10.3% during the forecast period (2025–2031).
________________________________________
🌐 Executive Summary & Global Market Outlook
The NdFeB magnet market is experiencing accelerated growth driven by the demand for high-performance, compact, and energy-efficient solutions across multiple industries. These powerful magnets are critical in the functionality of electric vehicles (EVs), wind turbines, consumer electronics, and medical devices, where strong magnetic performance and space efficiency are essential.
Key growth enablers include:
• Global shift toward renewable energy sources
• Rising electrification in automotive and industrial applications
• Continuous miniaturization and automation in electronics
As sustainability, recycling of rare earth elements, and resilient supply chains gain prominence, industry leaders are investing in advanced R&D, greener manufacturing, and localized sourcing strategies.
While Asia-Pacific remains a dominant hub for production, emerging players in North America and Europe are leveraging high-quality magnet innovation, environmental stewardship, and regional supply chains to capture market share.
📥 [Download Sample Report]- https://www.businessmarketinsights.com/reports/neodymium-iron-boron-permanent-magnet-market
________________________________________
📊 Market Segmentation Overview
By Type:
• Sintered NdFeB Magnets (Market leader in 2024)
• Bonded NdFeB Magnets
By End-User:
• Automotive (Largest share)
• Consumer Electronics
• Power Generation (Wind Turbines)
• Industrial Automation & Robotics
• Medical Devices
• Others
By Geography:
• Asia-Pacific (Dominant region)
• North America
• Europe
• Middle East & Africa
• South & Central America
________________________________________
⚡ Market Drivers & Emerging Opportunities
Electrification of Mobility:
The rapid global adoption of electric vehicles is a primary driver of NdFeB magnet demand. These magnets enable compact, energy-efficient EV motors that meet strict performance and sustainability standards.
Growth in Smart Manufacturing & Green Energy:
Industrial automation and renewable energy systems—particularly wind turbines—are creating robust demand for high-grade sintered NdFeB magnets capable of enduring extreme conditions and offering strong magnetic power.
________________________________________
🔍 Type-Based Insight
Sintered NdFeB magnets dominate the market owing to their high coercivity, thermal stability, and energy product. Produced through powder metallurgy, they are ideal for heavy-duty applications in EVs, aerospace, wind energy, and medical equipment.
________________________________________
🏭 Key Market Participants
• Hitachi Metals, Ltd.
• Shin-Etsu Chemical Co., Ltd.
• TDK Corporation
• Ningbo Yunsheng Co., Ltd.
• Beijing Zhong Ke San Huan High-Tech Co., Ltd.
• Vacuumschmelze GmbH & Co. KG
• Neo Performance Materials Inc.
________________________________________
🧩 About Us
Business Market Insights delivers actionable research across key industries including chemicals, automotive, healthcare, electronics, and aerospace. Our data-driven insights empower global organizations to make strategic, evidence-based decisions.
